World news and discussion on TalkFuse.
An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results
A 12-month trial of Spectris, a headset that delivers flickering light and sound to stimulate brainwaves, failed to show that it slowed cognitive decline across people with mild to moderate Alzheimer’s. The result weakens the case for the device as a non-drug treatment, though the company says it plans to seek US regulatory approval based on findings in mildly affected patients.
Among mildly affected participants, results suggested slower decline with the active device, especially for those who used it regularly; participants with moderate Alzheimer’s showed no benefit. Researchers cautioned that neither group’s results met the statistical threshold for reliable findings, and fewer than half of participants followed the recommended usage schedule. The trial involved 663 people, and its findings have not yet been peer-reviewed or published in a journal.
In short
- Spectris did not slow decline across the full trial group.
- Mild cases showed a possible benefit, but it was not statistically conclusive.
- Fewer than half used the headset as recommended.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
The trial’s overall result may obscure a possible benefit for people with mild Alzheimer’s: that subgroup appeared to decline more slowly, particularly among regular users. Since fewer than half followed the recommended schedule, supporters could argue that the study did not fully test the device under consistent use and that the signal merits further research.
The case against
The trial did not show reliable evidence that Spectris slowed cognitive decline: neither the mild nor moderate group’s results met the threshold for statistical confidence, and moderate participants showed no benefit. With findings not yet peer-reviewed, the evidence is too uncertain to establish the device as an effective treatment or support approval on the basis of this trial alone.